AltMountain

CF ON3 Lifesciences Parent DST

New York, NY · CIK 1928276 · Sponsor: Cantor Fitzgerald Investors, LLC
Status: no Form D since Feb 2023. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

CF ON3 Lifesciences Parent DST is a real estate fund based in New York, New York. According to its most recent Form D, filed Feb 28, 2023, it has sold $69,800,000 of interests to 116 investors since its first sale in May 2022. The minimum investment it accepts from an outside investor is $250,000. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Cantor Fitzgerald Investors, LLC; CF ON3 Lifesciences Depositor, LLC; CF ON3 Lifesciences Parent Manager, LLC.

Total raised
$69,800,000Cumulative sales reported on Form D
Investors
116
First sale
May 11, 2022
Minimum investment
$250,000
Who can invest
Not stated
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Cantor Fitzgerald Investors, LLC; CF ON3 Lifesciences Depositor, LLC; CF ON3 Lifesciences Parent Manager, LLC
Latest Form D
Feb 28, 2023

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌‌‌⁠

Raise history

FiledFilingTotal raisedInvestorsSource
Feb 28, 2023Form D/A (amendment)$69,800,000116SEC.gov ↗
May 23, 2022Form D$16,293,53525SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on May 23, 2022. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about CF ON3 Lifesciences Parent DST

What is the minimum investment for CF ON3 Lifesciences Parent DST?

According to its latest Form D, filed Feb 28, 2023, the minimum investment CF ON3 Lifesciences Parent DST accepts from an outside investor is $250,000.

Who can invest in CF ON3 Lifesciences Parent DST?

CF ON3 Lifesciences Parent DST is generally open only to investors who meet the eligibility rules in its offering documents. It uses Rule 506(b), which does not allow general advertising.

How much has CF ON3 Lifesciences Parent DST raised?

CF ON3 Lifesciences Parent DST reports $69,800,000 sold from 116 investors on its Form D filed Feb 28, 2023. This is cumulative sales since the offering began, not current assets or performance.

Where is CF ON3 Lifesciences Parent DST based?

CF ON3 Lifesciences Parent DST is based in New York, New York.

When did CF ON3 Lifesciences Parent DST launch?

CF ON3 Lifesciences Parent DST reports its first sale in May 2022.

Size compared with every real estate fund

Raised more than 95% of the 813 real estate funds based in New York, and more than 96% of all 7,351 that report sales.

Other programs from Cantor Fitzgerald Investors, LLC

All 62 funds from this sponsor

Other funds with the same team

More real estate funds in New York

Similar-size real estate funds in New York

All real estate funds in New York